CHNG:NSD-Change Healthcare Inc (USD)

COMMON STOCK | Health Information Services | NSD

Last Closing Price

USD 23.05

Change

+0.10 (+0.44)%

Market Cap

USD 7.03B

Volume

1.12M

Average Target Price

USD 23.04 (-0.04%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Change Healthcare Inc., an independent healthcare technology platform, provides data and analytics-driven solutions to enhance clinical, financial, administrative, and patient engagement outcomes in the United States healthcare system. It operates through three segments: Software and Analytics, Network Solutions, and Technology-Enabled Services. The Software and Analytics segment offers software and analytics solutions for financial performance, payment accuracy, clinical decision management, value-based payment, provider and consumer engagement, and imaging and clinical workflow. The Network Solutions segment enables financial, administrative, and clinical transactions; electronic business-to-business and consumer-to-business payments; and aggregation and analytics of clinical and financial data. The Technology-Enabled Services segment provides solutions for financial and administrative management, value-based care, communication and payment, pharmacy benefits administration, and healthcare consulting. Change Healthcare Inc. has a collaboration with Amazon Web Services, Inc. The company was founded in 2016 and is headquartered in Nashville, Tennessee.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-05-05 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
CERN Cerner Corporation

-0.88 (-1.17%)

USD22.81B 29.95 13.42
TXG 10x Genomics, Inc

-2.00 (-1.08%)

USD20.11B N/A N/A
GDRX GoodRx Holdings, Inc

-1.38 (-3.62%)

USD15.25B 927.27 238.21
RCM R1 RCM Inc

+0.40 (+1.68%)

USD6.30B 73.73 37.14
HQY HealthEquity, Inc

-0.72 (-0.97%)

USD6.17B 624.45 44.64
OMCL Omnicell, Inc

-0.50 (-0.36%)

USD6.00B 178.50 50.43
INOV Inovalon Holdings, Inc

+0.31 (+1.02%)

USD4.75B 140.51 27.23
PGNY Progyny, Inc

-0.74 (-1.37%)

USD4.75B 792.68 477.11
PINC Premier, Inc

+0.50 (+1.43%)

USD4.37B 13.78 10.62
CVET Covetrus, Inc

+0.28 (+0.93%)

USD4.12B 40.87 23.33

ETFs Containing CHNG

Symbol Name Weight Mer Price(Change) Market Cap
EVFTC Eaton Vance Floating-Rate.. 0.00 % 0.76 %

N/A

USD5.15M

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 23.59% 75% C 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.59% 75% C 72% C-
Trailing 12 Months  
Capital Gain 105.80% 69% D+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 105.80% 69% D+ 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 17.20% 50% F 66% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.20% 50% F 66% D
Risk Return Profile  
Volatility (Standard Deviation) 39.01% 50% F 45% F
Risk Adjusted Return 44.09% 46% F 65% D
Market Capitalization 7.03B 90% A- 88% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 2.18 85% B 62% D-
Price / Cash Flow Ratio -45.65 72% C- 91% A-
EV/EBITDA N/A N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -37.27% 29% F 28% F
Return on Invested Capital 0.12% 62% D- 53% F
Return on Assets -1.25% 52% F 42% F
Debt to Equity Ratio 143.37% 10% F 14% F
Technical Ratios  
Short Ratio 6.62 31% F 16% F
Short Percent 6.81% 44% F 31% F
Beta -11.16 100% A+ 100% A+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector